ChiroRab Rabies (Pre Exposure) Vaccine 1 ML at Chughtai Lab

ChiroRab Rabies (Pre Exposure) Vaccine 1 ML at Chughtai Lab

ChiroRab Rabies (Pre Exposure) Vaccine 1 ML at Chughtai Lab is a highly effective, sterile, purified chick embryo cell vaccine (PCECV) designed to provide active immunization against the rabies virus before potential exposure occurs. Rabies is a zoonotic, viral disease that causes acute, progressive, and almost invariably fatal encephalomyelitis. Once clinical symptoms appear, the mortality rate is virtually 100%. However, rabies is entirely preventable through timely and appropriate immunization. The ChiroRab vaccine works by stimulating the body's immune system to produce specific neutralizing antibodies against the rabies virus, ensuring that if an exposure does occur, the immune system can rapidly neutralize the virus before it accesses the central nervous system.

Administered at Chughtai Lab, Pakistan's premier diagnostic and clinical network, this vaccine is prepared using state-of-the-art biotechnology. The active ingredient consists of inactivated rabies virus (Flury LEP strain) grown on primary chicken fibroblast cell cultures. This advanced purification process minimizes the risk of systemic allergic reactions compared to older, nerve-tissue-derived vaccines. The anatomical target for this vaccine is the deltoid muscle in adults and older children, or the anterolateral aspect of the thigh in infants. It must never be administered in the gluteal region, as the adipose tissue in the buttocks can impede proper absorption and reduce the vaccine's immunogenic efficacy.

The clinical importance of pre-exposure prophylaxis (PrEP) cannot be overstated, particularly for individuals living in or traveling to rabies-endemic countries like Pakistan. Pre-exposure vaccination simplifies post-exposure management by eliminating the need for Rabies Immunoglobulin (RIG), which is often scarce, expensive, and difficult to obtain. It also reduces the number of post-exposure vaccine doses required, providing a critical safety net for those at high risk of unrecognized or unavoidable exposures.

Clinical Procedure: What to Expect

Patient Preparation

• No Fasting Required: Patients do not need to fast before receiving the ChiroRab vaccine; you may eat and drink normally.
• Medical History Disclosure: Inform the healthcare provider at Chughtai Lab of any known allergies, especially to egg proteins, neomycin, chlortetracycline, or amphotericin B, as these are used during the manufacturing process.
• Medication Review: Disclose all current medications, particularly immunosuppressive therapies, systemic corticosteroids, or antimalarial drugs like chloroquine, which may impair the immune response to the vaccine.
• Vaccination Records: Bring any previous immunization cards or records to help the clinician establish the correct dosing schedule.
• Appropriate Attire: Wear loose-fitting clothing or short sleeves to allow easy access to the upper arm (deltoid muscle).

During the Procedure

Upon arriving at the Chughtai Lab clinical center, you will be registered and escorted to a clean, sterile vaccination room. The trained nursing staff will verify your identity, medical history, and the specific vaccine prescription. You will be asked to sit comfortably in a chair. The clinician will clean the injection site—typically the deltoid muscle of your non-dominant arm—with an antiseptic swab and allow it to air dry.

The ChiroRab Rabies (Pre Exposure) Vaccine 1 ML is supplied as a freeze-dried powder (lyophilisate) with a sterile diluent. The nurse will aseptically reconstitute the vaccine immediately before administration. Using a sterile, single-use syringe, the 1 ML dose will be injected intramuscularly. You may feel a brief, mild pinching sensation or localized pressure during the injection. The entire procedure takes less than five minutes. After the injection, you will be advised to remain in the waiting area for 15 to 30 minutes so that healthcare professionals can monitor you for any immediate, rare allergic reactions.

When is a ChiroRab Rabies (Pre Exposure) Vaccine 1 ML Performed?

Veterinary and Animal Handling Professionals

Veterinarians, veterinary students, animal control officers, and zoo keepers are in constant contact with domestic and wild mammals. Because their occupational risk of animal bites, scratches, or saliva exposure is exceptionally high, routine pre-exposure vaccination with ChiroRab is medically recommended to establish baseline immunity.

Laboratory Personnel Working with Rabies Virus

Research and diagnostic laboratory staff who handle live rabies virus specimens, perform diagnostic testing, or conduct research on lyssaviruses are at risk of aerosol or accidental percutaneous exposure. For these professionals, pre-exposure vaccination is a mandatory safety protocol to prevent occupational infection.

Travelers to High-Risk Rabies Endemic Regions

International and domestic travelers visiting remote, rural, or high-risk areas within Pakistan or other endemic countries are highly advised to receive pre-exposure prophylaxis. This is especially critical if they plan to engage in outdoor activities like hiking, camping, or cycling, where access to immediate, high-quality medical care and post-exposure rabies biologics may be severely limited.

Wildlife Biologists and Forestry Workers

Fieldworkers, ecologists, and forestry personnel who study wild animal populations—particularly bats, stray dogs, jackals, and foxes—face unpredictable exposure risks. Pre-exposure vaccination ensures they maintain protective antibody levels while working in remote natural habitats.

Children Living in or Visiting High-Risk Areas

Children are statistically at the highest risk for rabies bites because they are naturally inclined to play with animals, may not recognize aggressive animal behavior, and often fail to report minor scratches or bites to their parents. Pre-exposure vaccination provides a vital layer of protection for children living in rabies-prone environments.

What Does a ChiroRab Rabies (Pre Exposure) Vaccine 1 ML Detect?

While the ChiroRab Rabies (Pre Exposure) Vaccine 1 ML is a preventive immunization rather than a diagnostic test, its administration triggers, monitors, and influences several critical physiological and immunological parameters:

• Induction of Rabies Virus Neutralizing Antibodies (RVNA): Stimulates B-lymphocytes to produce specific antibodies that target the rabies virus glycoprotein.
• Establishment of Immunological Memory: Creates long-lasting memory T and B cells that recognize and respond rapidly to future rabies virus exposures.
• Protective Antibody Titer Threshold: Aims to achieve a serum neutralizing antibody titer of at least 0.5 IU/mL, the internationally recognized protective threshold.
• Prevention of Viral Entry into Peripheral Nerves: Ensures antibodies are present to neutralize the virus at the site of exposure before it can bind to acetylcholine receptors.
• Blockade of Retrograde Axonal Transport: Prevents the virus from traveling along the peripheral nerves to the spinal cord and brain.
• Prevention of Acute Progressive Encephalomyelitis: Halts the viral replication cycle within the central nervous system.
• Mitigation of Classic Furious Rabies Symptoms: Prevents the onset of severe neurological symptoms such as hydrophobia, aerophobia, and extreme agitation.
• Prevention of Paralytic (Dumb) Rabies: Protects against the less common, progressive flaccid paralysis form of the disease.
• Evaluation of Primary Immune Competence: Serves as a clinical indicator of the patient's ability to mount an active humoral immune response.
• Identification of Vaccine-Induced Hypersensitivity: Monitors for immediate localized or systemic allergic reactions.
• Assessment of Localized Inflammatory Response: Evaluates normal physiological responses such as mild erythema, induration, or swelling at the injection site.
• Monitoring of Systemic Immunological Activation: Observes for transient, mild systemic symptoms like low-grade fever, headache, or myalgia.
• Verification of Correct Anatomical Administration: Ensures proper deltoid muscle delivery, avoiding accidental subcutaneous or gluteal administration.
• Confirmation of Pre-Exposure Immunization Status: Establishes documented proof of vaccination required for specific high-risk occupations.
• Determination of Booster Dose Requirements: Guides clinical decisions regarding the timing of booster doses for individuals with ongoing occupational risk.
• Assessment of Cross-Protection: Provides partial or full immunological cross-protection against other phylogroup 1 lyssaviruses.
• Detection of Immunological Interference: Monitors for reduced vaccine efficacy when co-administered with immunosuppressive agents.
• Evaluation of Vaccine Efficacy in Special Populations: Helps clinicians assess the immune response in elderly or mildly immunocompromised patients.
• Prevention of Salivary Gland Viral Shedding: Indirectly prevents the transmission cycle by protecting high-risk human vectors.
• Elimination of Rabies Immunoglobulin (RIG) Requirement: Ensures that in the event of a future exposure, the patient will not require expensive and scarce nerve-tissue or human-derived RIG.

Turnaround Time and Report Access at Chughtai Lab

At Chughtai Lab, the administration of the ChiroRab Rabies (Pre Exposure) Vaccine 1 ML is documented immediately. Upon receiving your vaccine, you will be issued an official Chughtai Healthcare Vaccination Card. This card details the vaccine brand name, batch number, manufacturer, date of administration, and the scheduled dates for your subsequent doses (if part of a multi-dose primary series).

For patients who require confirmation of their immune response (typically recommended for high-risk laboratory personnel every 6 to 24 months), Chughtai Lab offers Rabies Antibody Titer testing. The turnaround time for antibody titer reports is generally within a few working days. All vaccination records and subsequent laboratory reports are securely uploaded to the Chughtai Lab online portal. Patients can easily access, download, and print their official reports and vaccination history via the My Chughtai App or the official Chughtai Lab website using their unique patient ID.

ChiroRab Rabies (Pre Exposure) Vaccine 1 ML Findings Overview

Structure / Parameter Evaluated	Normal Findings	Possible Abnormal Findings
Immune Response (RVNA Titer)	Serum neutralizing antibody titer >= 0.5 IU/mL	Inadequate antibody response (titer < 0.5 IU/mL)
Injection Site Condition	No reaction or mild, transient redness and tenderness	Severe swelling, persistent pain, sterile abscess, or cellulitis
Systemic Temperature	Normal body temperature (< 100.4°F or 38°C)	Moderate to high-grade fever (> 101°F)
Allergic/Hypersensitivity Response	No immediate or delayed allergic reactions	Anaphylaxis, generalized urticaria, or angioedema (rare)
Neurological Status	No post-vaccination neurological deficits	Paresthesia, weakness, or Guillain-Barré syndrome (extremely rare)
Administration Route Accuracy	Confirmed intramuscular delivery in the deltoid muscle	Accidental subcutaneous or gluteal administration
Schedule Compliance	All doses administered on days 0, 7, and 21 or 28	Missed doses or prolonged intervals between injections
Drug-Vaccine Interactions	No interference from concurrent medications	Suppressed immune response due to immunosuppressant drugs

Note: Diagnostic findings should always be interpreted by a qualified healthcare professional together with the patient’s symptoms, medical history, physical examination, laboratory investigations, previous imaging studies, and other relevant clinical information. Additional investigations or specialist consultation may be recommended depending on the findings.

Why Choose Chughtai Lab for ChiroRab Rabies (Pre Exposure) Vaccine 1 ML?

• Experienced Healthcare Professionals: Our clinical staff and nurses are highly trained in aseptic vaccine reconstitution and precise intramuscular administration techniques.
• Strict Cold Chain Maintenance: Chughtai Lab utilizes advanced, continuous temperature-monitoring systems to ensure the ChiroRab vaccine is stored at the optimal 2°C to 8°C, preserving its potency.
• Patient-Focused Care: We prioritize patient comfort, safety, and thorough pre-vaccination screening to minimize risks.
• Professional Reporting and Documentation: Receive an official, verifiable vaccination card and digital records accessible anytime.
• Modern Diagnostic Approach: Access to state-of-the-art facilities for follow-up rabies antibody titer testing if required.
• Comfortable and Sterile Environment: Our vaccination rooms are maintained under strict hygiene and infection-control protocols.
• Convenient Nationwide Locations: With clinical centers across Lahore, Karachi, Islamabad, and other major cities, accessing your vaccine is simple.
• Commitment to Accurate Diagnosis and Prevention: Chughtai Lab is dedicated to supporting public health through high-quality preventive medicine and immunization services.